eIF-2
|
WikiDoc Resources for EIF-2 |
|
Articles |
|---|
|
Media |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on EIF-2 at Clinical Trials.gov Clinical Trials on EIF-2 at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on EIF-2
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Directions to Hospitals Treating EIF-2 Risk calculators and risk factors for EIF-2
|
|
Healthcare Provider Resources |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
eIF-2 (Eukaryotic Initiation Factor 2) is a heterotrimer of subunits alpha, beta, and gamma. eIF-2 mediates the binding of methionyl-tRNAimet to the ribosome in a GTP-dependent manner.
eIF-2 is released from the ribosome bound to GDP as an inactive binary complex.
To participate in another round of translation initiation, this GDP must be exchanged for GTP.
Under steady-state conditions of translation, eIF-2 must be recycled in order to participate in another round of translation initiation.
eIF-2B
Conversion of the inactive eIF-2-GDP to the active eIF-2-GTP form is catalyzed by a guanine nucleotide exchange factor, eIF-2B.
Phosphorylation of the alpha subunit of eIF-2 inhibits translation initiation by impairing the eIF-2B-catalyzed guanine nucleotide exchange reaction.
See also
External links
- EIF-2 at the US National Library of Medicine Medical Subject Headings (MeSH)